Novel 4-anilino quinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors - Hennequin, L; Stokes, E S; Thomas, A P (J Med Chem, 2002)
et al.